Late potentials in the signal-averaged electrocardiogram in schizophrenia patients maintained on antipsychotic agents. A preliminary naturalistic study

European Neuropsychopharmacology

Volumn 20, Issue 3, 2010, Pages 146-152

  Nahshoni, Eitan ^a,d   Strasberg, Boris ^b,d   Imbar, Shula ^b,d   Rotem, Ofer ^c   Gur, Shay ^a,d   Hermesh, Hagai ^a,d   Weizman, Abaraham ^a,b,d  

^a GEHA MENTAL HEALTH CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Late potentials; Schizophrenia; Sudden cardiac death

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; NEUROLEPTIC AGENT; PERPHENAZINE; RISPERIDONE; THIORIDAZINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART MUSCLE POTENTIAL; HEART VENTRICLE ARRHYTHMIA; HUMAN; MALE; MORBIDITY; MORTALITY; NATURALISTIC INQUIRY; PATIENT ASSESSMENT; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SUDDEN DEATH;

ADULT; ANTIPSYCHOTIC AGENTS; ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PILOT PROJECTS; SCHIZOPHRENIA; TIME FACTORS;

EID: 75149147629     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2009.12.001     Document Type: Article

References (46)

1. Abboud S., and Sadeh D. The use of cross-correlation function for the alignment of ECG waveforms and rejection of extrasystoles. Comput. Biomed. Res. 17 (1984) 258-266
2. Adamantidis M.M., Kerram P., and Dupuis B.A. In vitro electrophysiological detection of iatrogenic arrhythmogenicity. Fundam. Clin. Pharmacol. 8 (1994) 391-407
3. Allebeck P., and Wistedt B. Mortality in schizophrenia. A ten-year follow-up based on the Stockholm County inpatient register. Arch. Gen. Psychiatry 43 (1986) 650-653
4. Bär K.J., Letzsch A., Jochum T., Wagner G., Greiner W., and Sauer H. Loss of efferent vagal activity in acute schizophrenia. J. Psychiatr. Res. 39 (2005) 519-527
5. Bär K.J., Wernich K., Boettger S., Cordes J., Boettger M.K., Löffler S., Kornischka J., and Agelink M.W. Relationship between cardiovagal modulation and psychotic state in patients with paranoid schizophrenia. Psychiatry Res. 157 (2007) 255-257
6. Bär K.J., Wernich K., Boettger S., Cordes J., Boettger M.K., Löffler S., Kornischka J., and Agelink M.W. Relationship between cardiovagal modulation and psychotic state in patients with paranoid schizophrenia. Psychiatry Res. 157 (2008) 255-257
7. Bazett H.C. An analysis of the time relations of electrocardiograms. Heart 7 (1920) 353-370
8. Boettger S., Hoyer D., Falkenhahn K., Kaatz M., Yeragani V.K., and Bär K.J. Altered diurnal autonomic variation and reduced vagal information flow in acute schizophrenia. Clin. Neurophysiol. 117 (2006) 2715-2722
9. Breithardt G., Cain M.E., el-Sherif N., Flowers N.C., Hombach V., Janse M., Simson M.B., and Steinbeck G. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography. A statement by a Task Force Committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. Circ. vol. 83 (1991) 1481-1488
10. Chew M.L., Mulsant B.H., Pollock B.G., Lehman M.E., Greenspan A., Mahmoud R.A., Kirshner M.A., Sorisio D.A., Bies R.R., and Gharabawi G. Anticholinergic activity of 107 medications commonly used by older adults. J. Am. Geriatr. Soc. 56 (2008) 1333-1341
11. Christiansen E.H., and Frøbert O. Effect of parasympathetic blockade on the signal-averaged electrocardiogram. Clin. Auton. Res. 8 (1998) 165-171
12. Christiansen E.H., Frost L., Mølgaard H., Nielsen T.T., and Pedersen A.K. Association Between Parasympathetic Activity and Late Potentials at Low Noise Level. A.N.E. vol. 2 (1997) 254-263
13. c interval and its dispersion in patients receiving two atypical antipsychotics. Eur. Arch. Psychiatry Clin. Neurosci. 259 (2008) 23-27
14. Day C.P., McComb J.M., and Campbell R.W.F. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br. Heart J. 63 (1990) 342-344
15. Drici M.D., Wang W.X., Liu X.K., Woosley R.L., and Flockhart D.A. Prolongation of QT interval in isolated feline hearts by antipsychotic drugs. J. Clin. Psychopharmacol. 18 (1998) 477-481
16. Engel G., Beckerman J.G., Froelicher V.F., Yamazaki T., Chen H.A., Richardson K., McAuley R.J., Ashley E.A., Chun S., and Wang P.J. Electrocardiographic arrhythmia risk testing. Curr. Probl. Cardiol. 29 (2004) 365-432
17. Structured Clinical Interview for Axis DSM IV disorders. In: First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. (Eds). Patient Edition (SCID-I/P 2.0). Biometrics Research Department (1996), NY State Psychiatric Institute, New York
18. Glassman A.H. Schizophrenia, antipsychotic drugs, and cardiovascular disease. J. Clin. Psychiatry 66 Suppl 6 (2005) S5-S10
19. Gluais P., Bastide M., Caron J., and Adamantidis M. Risperidone prolongs cardiac action potential through reduction of K+ currents in rabbit myocytes. Eur. J. Pharmacol. 444 (2002) 123-132
20. Graham A.A., and Handelsman H. Signal-averaged electrocardiography. Health Technol. Assess. (Rockv) 11 (1998) 1-15
21. c prolongation, torsade de pointes and sudden death. Drugs 62 (2002) 1649-1671
22. Huffaker S.J., Chen J., Nicodemus K.K., Sambataro F., Yang F., Mattay V., Lipska B.K., Hyde T.M., Song J., Rujescu D., Giegling I., Mayilyan K., Proust M.J., Soghoyan A., Caforio G., Callicott J.H., Bertolino A., Meyer-Lindenberg A., Chang J., Ji Y., Egan M.F., Goldberg T.E., Kleinman J.E., Lu B., and Weinberger D.R. A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat. Med. 15 (2009) 509-518
23. Huston J.R., and Bell G.E. The effects of thioridazine hydrochloride and chlorpromazine on the electrocardiogram. JAMA 198 (1966) 16-20
24. Kelly D.L., Wehring H.J., Linthicum J., Feldman S., McMahon R.P., Love R.C., Wagner T., Shim J.C., and Fowler D.R. Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone. Schizophr Res. 107 (2009) 134-138
25. c dispersion, but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease. Eur. J. Clin. Pharmacol. 55 (1999) 259-262
26. Kongsamut S., Kang J., Chen X.L., Roehr J., and Rampe D. A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs. Eur. J. Pharmacol. 450 (2002) 37-41
27. Lander P., Berbari E.J., Rajagopalan C.V., Vatterott P., and Lazzara R. Critical analysis of the signal-averaged electrocardiogram. Improved identification of late potentials. Circles 87 (1993) 105-117
28. Laursen T.M., Munk-Olsen T., Agerbo E., Gasse C., and Mortensen P.B. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch. Gen. Psychiatry 66 (2009) 713-720
29. Malaspina D., Bruder G., Dalack G.W., Storer S., Van Kammen M., Amador X., Glassman A., and Gorman J. Diminished cardiac vagal tone in schizophrenia: associations to brain laterality and age of onset. Biol. Psychiatry 41 (1997) 612-617
30. Mantel-Teeuwisse A.K., Klungel O.H., Verschuren W.M., Porsius A., and de Boer A. Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J. Clin. Epidemiol. 54 (2001) 1181-1186
31. Mladosievicova B., Hulin I., Pogady J., Martisova D., Petrasova H., and Hubka P. Signal-averaged ECG in patients with antidepressant therapy. Int. J. Cardiol. 54 (1996) 27-31
32. Nahshoni E., Manor N., Bar F., Stryjer R., Zalsman G., and Weizman A. Alterations in QT dispersion in medicated schizophrenia patients following electroconvulsive therapy. Eur. Neuropsychopharmacol. 14 (2004) 121-125
33. Newcomer J.W. Antipsychotic medications: metabolic and cardiovascular risk. J. Clin. Psychiatry 68 Suppl 4 (2007) S8-13
34. Newman S.C., and Blanc R.C. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can. J. Psychiatry 36 (1991) 239-245
35. Ray W.A., Meredith S., Thapa P.B., Meador K.G., Hall K., and Murray K.T. Antipsychotics and the risk of sudden cardiac death. Arch. Gen. Psychiatry 58 (2001) 1161-1167
36. Ray W.A., Chung C.P., Murray K.T., Hall K., and Stein C.M. Atypical antipsychotic drugs and the risk of sudden cardiac death. N. Engl. J. Med. 360 (2009) 225-235
37. c-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355 (2000) 1048-1052
38. Ruschena D., Mullen P.E., Burgess P., Cordner S.M., Barry-Walsh J., Drummer O.H., Palmer S., Browne C., and Wallace C. Sudden death in psychiatric patients. Br. J. Psychiatry 172 (1998) 331-336
39. Santangeli P., Infusino F., Sgueglia G.A., Sestito A., and Lanza G.A. Ventricular late potentials: a critical overview and current applications. J. Electrocardiol. 41 (2008) 318-324
40. Schweitzer P. The values and limitations of the QT interval in clinical practice. Am. Heart J. 124 (1992) 1121-1124
41. Takimoto Y., Yoshiuchi K., Kumano H., and Kuboki T. Bulimia nervosa and abnormal cardiac repolarization. J. Psychosom. Res. 60 (2006) 105-107
42. Williams L.M., Das P., Harris A.W., Liddell B.B., Brammer M.J., Olivieri G., Skerrett D., Phillips M.L., David A.S., Peduto A., and Gordon E. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am. J. Psychiatry 161 (2004) 480-489
43. Witchel H.J., Hancox J.C., and Nutt D.J. Psychotropic drugs, cardiac arrhythmia, and sudden death. J. Clin. Psychopharmacol. 23 (2003) 58-77
44. Yakubo S., Ozawa Y., Saito S., Kasamaki Y., Komaki K., Hanakawa K., Sasaki Y., Aruga M., Miyazawa I., Kanda T., Sekiguchi K., Shimabukuro H., Nakamura T., and Okumura N. Normal limits of high-resolution signal-averaged ECG parameters of Japanese adult men and women. J. Electrocardiol. 33 (2000) 225-231
45. Yang T.F., and Macfarlane P.W. New sex dependent normal limits of the signal averaged electrocardiogram. Br. Heart J. 72 (1994) 197-200
46. Zahn T.P., and Pickar D. Autonomic activity in relation to symptom ratings and reaction time in unmedicated patients with schizophrenia. Schizophr. Res. 79 (2005) 257-270